{"text": "the bristol myers squibb janssen bmy jnj collaboration launches pivotal phase 3 librexia clinical trial program evaluating milvexian an investigational oral factor xia inhibitor"}
{"text": "march 1 bristol myers won dismissal re bmyrt class action suit accusing bmy of defrauding investors of payout related to celgene merger investors attorneys have 30 days to amend the complaint which bmy will again ask to be dismissed or appeal they intend to do something"}
{"text": "pharmalot pharmalittle good morning fda panel backs a gsk vaccine for rsv opioid wholesalers cleared of liability to georgia families amp more news pharma covid19 rsv vaccines medicare opioids alzheimers pfe gsk bmy mck cah esaiy"}
{"text": "bmy amp jnj have started their phase 3 studies of milvexian here s my previous take on the decision to push on despite the phase 2 disappointment"}
{"text": "join the thousands of traders who trust trade ideas for their trading needs apt tdoc bmy inpx crsr huya mmat incy tradingcommunity bynd"}
{"text": "bms j amp j kick off pivotal studies of fxia inhibitor milvexian bmy jnj"}
